Literature DB >> 19940502

Tryptase is not cleared by the kidneys into the urine.

Michael R Simon1, Mindy Jan, Jerry Yee, Uday S Nori, Jiang Hu, Cem Akin, Lawrence B Schwartz.   

Abstract

BACKGROUND: Patients with chronic kidney disease have been reported to have increased concentrations of blood tryptase. Detection of tryptase in the urine of healthy subjects has been reported.
OBJECTIVE: The objective is to determine whether tryptase is indeed cleared by the kidneys.
METHODS: Blood and urine collections were performed in healthy and systemic mastocytosis subjects. Total and mature tryptase concentrations in blood and total tryptase concentrations in urine were determined.
RESULTS: Total tryptase levels in urine were below the limit of detection in both healthy subjects and those with systemic mastocytosis, even after concentrating the urine 10-fold. Thus, both mature and protryptase levels in urine are <0.2 ng/ml.
CONCLUSION: Tryptase is not cleared by the kidneys into the urine. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940502      PMCID: PMC2956006          DOI: 10.1159/000260080

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

1.  Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells.

Authors:  Lawrence B Schwartz; Hae-Ki Min; Shunlin Ren; Han-Zhang Xia; Jiang Hu; Wei Zhao; George Moxley; Yoshihiro Fukuoka
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

2.  Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus.

Authors:  Susanne Dugas-Breit; Pia Schöpf; Martin Dugas; Helmut Schiffl; Franziska Ruëff; Bernhard Przybilla
Journal:  J Dtsch Dermatol Ges       Date:  2005-05       Impact factor: 5.584

Review 3.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

Review 4.  Diagnostic value of tryptase in anaphylaxis and mastocytosis.

Authors:  Lawrence B Schwartz
Journal:  Immunol Allergy Clin North Am       Date:  2006-08       Impact factor: 3.479

5.  Elevated mast cell tryptase in the urine of patients with interstitial cystitis.

Authors:  W Boucher; M el-Mansoury; X Pang; G R Sant; T C Theoharides
Journal:  Br J Urol       Date:  1995-07

6.  Elevated SCF levels in the serum of patients with chronic renal failure.

Authors:  T Kitoh; H Ishikawa; T Ishii; S Nakagawa
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

7.  Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.

Authors:  J J Costa; G D Demetri; T J Harrist; A M Dvorak; D F Hayes; E A Merica; D M Menchaca; A J Gringeri; L B Schwartz; S J Galli
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

  7 in total
  3 in total

Review 1.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

2.  HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

Authors:  Christian A Fernandez; Colton Smith; Wenjian Yang; Mihir Daté; Donald Bashford; Eric Larsen; W Paul Bowman; Chengcheng Liu; Laura B Ramsey; Tamara Chang; Victoria Turner; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick Concannon; Stephen S Rich; Paul Scheet; Sima Jeha; Ching-Hon Pui; William E Evans; Meenakshi Devidas; Mary V Relling
Journal:  Blood       Date:  2014-06-26       Impact factor: 22.113

3.  Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

Authors:  Almudena Matito; José Mario Morgado; Iván Álvarez-Twose; Laura Sánchez-Muñoz; Carlos Eduardo Pedreira; María Jara-Acevedo; Cristina Teodosio; Paula Sánchez-López; Elisa Fernández-Núñez; Ricardo Moreno-Borque; Andrés García-Montero; Alberto Orfao; Luis Escribano
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.